Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies
Gilead Sciences (NASDAQ: GILD) Delayed: 150.93 +1.24 (0.83%)
Previous Close $149.69    52 Week High $108.63 
Open $150.05    52 Week Low $71.39 
Day High $151.00    P/E 83.39 
Day Low $148.02    EPS $1.81 
Volume 5,284,287       

MACROGENICS (NASDAQ: MGNX) Delayed: 3.74 -0.06 (1.58%)
Previous Close $3.80    52 Week High $36.11 
Open $3.79    52 Week Low $14.84 
Day High $3.86    P/E 9.59 
Day Low $3.72    EPS $0.39 
Volume 604,617